KMX vs VTGN · P/E 19, rev $25.88B vs rev $1.3M
CarMax Inc (KMX) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 161.1% from 2025-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
KMX currently screens at market cap $10.26B and trailing P/E 18.9. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the KMX and VTGN stock pages for the full models.
Not investment advice.